NCC Medical Group is a globally recognized manufacturer and developer of advanced neurophysiology monitoring technologies. As a nationally designated SRDI “Little Giant” enterprise, NCC represents a new generation of specialized medical device companies that focus on innovation, precision engineering, and high-value medical technologies.
Founded in 1997, NCC has accumulated more than two decades of expertise in neurophysiology research, product development, and medical device manufacturing. The company’s primary research and manufacturing headquarters are located in Shanghai, China, a major international center for medical technology innovation. At this facility, multidisciplinary teams of biomedical engineers, neurophysiology specialists, and manufacturing experts collaborate to develop advanced solutions for neurological diagnostics and intraoperative monitoring.
To ensure global regulatory compliance and international quality management, NCC also operates a dedicated quality and compliance center in Singapore. This center oversees international product certification, regulatory strategy, and quality assurance processes for global markets.
NCC specializes in the development of comprehensive neurophysiology technologies, including intraoperative neuromonitoring (IONM) systems, electroencephalography (EEG) systems, polysomnography (PSG) systems, electromyography (EMG) devices, and a wide range of specialized neurophysiology consumables. These products are widely used by hospitals and surgical centers to improve diagnostic accuracy and enhance patient safety during complex medical procedures.
The company’s operational framework is built on three strategic pillars that support global growth and technological innovation.
The first pillar focuses on research and manufacturing excellence. NCC invests heavily in neurophysiology research and advanced production technologies, ensuring that each monitoring system meets the highest standards of performance and reliability.
The second pillar emphasizes global sales and distribution development. Through strategic partnerships with international distributors and healthcare institutions, NCC has expanded its market presence across Southeast Asia, Australia, Europe, the Americas, and Africa.
The third pillar centers on clinical service and professional education. Through platforms such as the NeuGuard Service Platform and the NCC Innovation Academy, NCC provides clinical training, technical support, and continuing education programs for healthcare professionals.
Today, NCC’s neurophysiology monitoring solutions are used in more than 50 countries and installed in over 5,000 hospitals across China. These technologies help surgeons perform safer procedures and enable clinicians to obtain accurate neurophysiological data for diagnosis and treatment.
To further support healthcare institutions, NCC operates 31 training and technical support centers across China. These centers provide hands-on training for clinicians, biomedical engineers, and technical staff, ensuring that hospitals can effectively implement advanced neurophysiology monitoring technologies.
Guided by its mission of “Safeguarding Life and Health,” NCC continues to innovate in the fields of neuromonitoring, neurodiagnostics, and surgical safety technologies, delivering reliable solutions that support better clinical outcomes worldwide.
Copyright © NCC Medical Co., Ltd. - Privacy policy